Immune Checkpoint Inhibitors as Maintenance Therapy for Solid Tumors Real-World Evidence in NSCLC Guides Clinical Decisions Register: A New Wave of Progress in the Treatment of Multiple Myeloma Risk Factors of Cardiovascular Disease and Management of Prostate Cancer Updates in the Treatment of Chronic GVHD

Immune Checkpoint Inhibitors as Maintenance Therapy for Solid TumorsReal-World Evidence in NSCLC Guides Clinical Decisions Register: A New Wave of Progress in the Treatment of Multiple MyelomaRisk Factors of Cardiovascular Disease and Management of Prostate CancerUpdates in the Treatment of Chronic GVHD

Clinical

View More Brain Cancer Breast Cancer Colorectal Cancer Gastrointestinal Cancer Genitourinary Cancer Gynecologic Cancer Hematology Leukemia Lung Cancer Lymphoma Pediatric Cancers Skin Cancer

Brain CancerBreast CancerColorectal CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHematologyLeukemiaLung CancerLymphomaPediatric CancersSkin Cancer

News

Clinical Topics Integrative Care All News

Clinical TopicsIntegrative CareAll News

Media

Around the Practice Between the Lines Clinical Consult Expert Interviews Medical World News OncView Podcasts Readout 360 Year in Review

Around the PracticeBetween the LinesClinical ConsultExpert InterviewsMedical World NewsOncViewPodcastsReadout 360Year in Review

Conferences

Publications

All Journals For Authors Tumor Board

All JournalsFor AuthorsTumor Board

CME/CE

Resources

Contemporary Concepts Interactive Tools Nurse Practitioners/Physician's Assistants Partners Sponsored

Contemporary ConceptsInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsored

eNewsletter Print Subscription

eNewsletterPrint Subscription

About
Advertise
CureToday.com
OncLive.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Spotlight

Immune Checkpoint Inhibitors as Maintenance Therapy for Solid Tumors
Real-World Evidence in NSCLC Guides Clinical Decisions
Register: A New Wave of Progress in the Treatment of Multiple Myeloma
Risk Factors of Cardiovascular Disease and Management of Prostate Cancer
Updates in the Treatment of Chronic GVHD

ClinicalSee All >

Brain Cancer
Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer

About
Advertise
CureToday.com
OncLive.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Readout 360

Refining Combination Strategies in Metastatic RCC

March 17th 2021

Drs Toni Choueiri and Robert J. Motzer reflect on recent data supporting the use of TKI/I-O combination regimens for frontline treatment of metastatic renal cell carcinoma.